Bank Of America Corp Nemaura Medical Inc. Transaction History

Bank Of America Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.78 - $4.66 $521 - $643	-138 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$4.12 - $6.35 $70 - $107	17 Added 14.05%	138 $1,000
Q3 2021 Nov 15, 2021	SELL	$5.76 - $9.95 $9,198 - $15,890	-1,597 Reduced 92.96%	121 $1,000
Q2 2021 Sep 13, 2021	BUY	$4.7 - $16.7 $8,074 - $28,690	1,718 New	1,718 $17,000

20.8K

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $1.45M
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.